< Back to previous page

Project

VersaTile antibodies (VersaTile Antibody)

The inferior quality of poorly validated antibodies supplied by the major market players often disappoint customers who purchase these antibodies as a research or diagnostic reagent. These antibodies are usually of polyclonal or monoclonal descent, and exhibit poor reproducibility because their sequences are unknown. Therefore, there is an increasing demand for validated synthetic antibodies at competitive prices. VersaTile is a modular DNA assembly method that has been extensively validated outside the antibody domain. In this project we aim to provide a proof-of-concept dataset that will be used to develop a business case and to attract venture capital for starting a new business.

Date:1 Apr 2020 →  31 Mar 2022
Keywords:Synthetic libraries, VersaTile, Research and diagnostic reagents, Newco, Antibody
Disciplines:Biochemical engineering, Medical molecular engineering of nucleic acids and proteins